We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
TransDigm Group (TDG) to Report Q3 Earnings: What's in Store?
Read MoreHide Full Article
Transdigm Group Incorporated (TDG - Free Report) is set to report third-quarter fiscal 2020 results on Aug 4, before market open.
In the last reported quarter, the company delivered a positive earnings surprise of 33.16%. Moreover, it surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an earnings surprise of 16.69% on average.
Let’s see how things have shaped up prior to this announcement.
Factors at Play
Revenue passenger miles (RPM), which has been historically a key growth factor boosting Transdigm’s commercial aftermarket sales, witnessed a sharp decline during the April-June quarter, courtesy of the novel coronavirus outbreak worldwide. Notably, inthe last three weeks of the fiscal second-quarter, the company witnessed weak OEM sales owing to the COVID-19 pandemic.
Transdigm Group Incorporated Price and EPS Surprise
Considering the fact that the impact of the pandemic further intensified during the fiscal third quarter, we remain skeptical about how the company’s top line performance might have been.
The Zacks Consensus Estimate for fiscal third-quarter revenues is pegged at $1.01billion, indicating a deterioration of 39.3% from third-quarter fiscal 2019.
An expected fall in demand for commercial OEM products, due to reductions in OEM production rates and airlines deferring or canceling new prolonged grounding of Boeing’s (BA - Free Report) 737 MAX and subsequent production rate cuts might have had a moderate impact on the to-be-reported quarter’s results.
This along with the dismal sales projections might have weighed on the company’s fiscal third-quarter earnings.
The Zacks Consensus Estimate stands at 99 cents per share, implying a huge plunge of 80% from the year-ago quarter’s reported figure.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Transdigm Group in the fiscal third quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter..
Transdigm Group has an Earnings ESP of -6.88% and a Zacks Rank #4 (Sell).
A Stock to Consider
Here is a defense company you may want to consider, as our model shows that it has the right combination of elements to post an earnings beat this quarter:
Lockheed Martin (LMT - Free Report) reported second-quarter 2020 adjusted earnings of $6.13 per share, which surpassed the Zacks Consensus Estimate of $5.71 by 7.4%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
TransDigm Group (TDG) to Report Q3 Earnings: What's in Store?
Transdigm Group Incorporated (TDG - Free Report) is set to report third-quarter fiscal 2020 results on Aug 4, before market open.
In the last reported quarter, the company delivered a positive earnings surprise of 33.16%. Moreover, it surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an earnings surprise of 16.69% on average.
Let’s see how things have shaped up prior to this announcement.
Factors at Play
Revenue passenger miles (RPM), which has been historically a key growth factor boosting Transdigm’s commercial aftermarket sales, witnessed a sharp decline during the April-June quarter, courtesy of the novel coronavirus outbreak worldwide. Notably, inthe last three weeks of the fiscal second-quarter, the company witnessed weak OEM sales owing to the COVID-19 pandemic.
Transdigm Group Incorporated Price and EPS Surprise
Transdigm Group Incorporated price-eps-surprise | Transdigm Group Incorporated Quote
Considering the fact that the impact of the pandemic further intensified during the fiscal third quarter, we remain skeptical about how the company’s top line performance might have been.
The Zacks Consensus Estimate for fiscal third-quarter revenues is pegged at $1.01billion, indicating a deterioration of 39.3% from third-quarter fiscal 2019.
An expected fall in demand for commercial OEM products, due to reductions in OEM production rates and airlines deferring or canceling new prolonged grounding of Boeing’s (BA - Free Report) 737 MAX and subsequent production rate cuts might have had a moderate impact on the to-be-reported quarter’s results.
This along with the dismal sales projections might have weighed on the company’s fiscal third-quarter earnings.
The Zacks Consensus Estimate stands at 99 cents per share, implying a huge plunge of 80% from the year-ago quarter’s reported figure.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Transdigm Group in the fiscal third quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter..
Transdigm Group has an Earnings ESP of -6.88% and a Zacks Rank #4 (Sell).
A Stock to Consider
Here is a defense company you may want to consider, as our model shows that it has the right combination of elements to post an earnings beat this quarter:
Leidos Holdings, Inc. (LDOS - Free Report) has an Earnings ESP of +0.11% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
A Recent Defense Release
Lockheed Martin (LMT - Free Report) reported second-quarter 2020 adjusted earnings of $6.13 per share, which surpassed the Zacks Consensus Estimate of $5.71 by 7.4%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>